| abstract |
A method of treating septic shock in a mammal including the administration of a septic shock-treating effective amount of thymosin beta 4 (T beta 4) to the mammal. Included is a process directed to obstructing the progression of sepsis cascade by administration of a sepsis cascade progression-obstructing amount of T beta 4. Further included is a process directed to preventing septic shock by administration of a septic shock-preventing effective amount of T beta 4. |